The company is significantly improved this progress of the novel treatment for ATTR-CM, utilizing Attruby. Early trial results reveals potential benefits for patients diagnosed by the serious condition. The focus represents researchers’ dedication to managing unmet medical demands in this cardiology arena. Attruby: BridgeBio's Novel Approach to